Study suggests protective effect of ergocalciferol on beta cells in new-onset type 1 diabetes
USA: A secondary analysis of a randomized clinical trial (RCT) published as a research letter in JAMA Network Open has shed light on the effect of ergocalciferol, an inactivated vitamin D analog, on β-cell function in new-onset type 1 diabetes (T1D). The researchers showed that high-dose ergocalciferol, also known as vitamin D2, may help preserve […]